Please input keywords

Terms and Conditions

READ THESE TERMS AND CONDITIONS ("Terms") CAREFULLY BEFORE REGISTERING OR USING THE SERVICES DESCRIBED ON THE WEBSITE LOCATED AT By clicking the "Accept" button, you consent to be bound by all the terms set out herein. If you do not agree with any of these terms, you are not an authorized user for these services and you should not use this website. Please click "Do not Accept" button and leave this website.

Terms and Conditions

China Asset Management (Hong Kong) Limited ("ChinaAMC HK") is a regulated institution in Hong Kong by the Securities and Futures Commission (“SFC”) pursuant to the Securities and Futures Ordinance (Cap 571). This website is prepared and owned by ChinaAMC HK and contains information about ChinaAMC HK and the services and products offered by ChinaAMC HK. This website has not been reviewed by the SFC.

This information contained in this website is provided for informational purposes only. Funds information is intended to be made available only to residents in Hong Kong that are not U.S. Persons. If you are an individual investor, you acknowledge that you are a resident of Hong Kong. Funds information is not intended for use by any person located in or residing in any jurisdiction that restrict the use or distribution of such information. Nothing on this website should constitute a distribution, an offer to buy or the solicitation of any offer to buy or sell any securities in any jurisdiction where such a distribution or offer would be illegal. Non-Hong Kong investors are responsible for observing all applicable laws and regulations of their relevant jurisdictions before proceeding to access the information contained herein. By proceeding, you are representing that you have understood and accepted the restrictions set out in this section.

None of the information contained in this website constitute an invitation or solicitation to invest in any shares or units of the Funds, nor does it constitute any investment advice or recommendation to acquire or dispose of any investment or to engage in any transactions. Before acting on any information in this website, you should consider whether any investment, security or strategy is suitable for your particular circumstance and, if necessary, seek independent professional advice.

Investment involves risks. The price of units or shares of the Funds may go up as well as down. Past performance is not indicative of future results. The value of the Funds can be extremely volatile and could go down substantially within a short period of time. It is possible that the entire value of your investment could be lost. An investment in a Fund often involves investing in international markets. In addition to the normal risks associated with investing, international investments involve the risk of losing all or part of any capital from unfavorable fluctuations in currency values, from differences in generally accepted accounting principles or from economic or political instability in other nations. An investment in emerging markets also involves heightened other risks such as increased volatility and the possibility of lower trading volume. Funds may use or invest in financial derivatives. Please read the Funds’ Prospectuses and Product Key Fact Statements for details, including the risk factors, before making any investment decision.

Where a Fund's investment objective is to track an index, the Fund is not sponsored, endorsed, issued, sold or promoted by the relevant index provider. None of these companies make any representation regarding the advisability of investing in the Funds. Index returns are for illustrative purposes only and do not represent actual fund performance. Index performance returns do not reflect any management fees, transaction costs or expenses. Indices are unmanaged and one cannot invest directly in an index.

Prohibited Uses

Except as otherwise stated in these Terms or as expressly authorized by ChinaAMC HK in writing, you may not:

Use this website in any manner that could damage or overburden any ChinaAMC server, or any network connected to any ChinaAMC server, as all servers have limited capacity and are used by many people;

Use this website in any manner that would interfere with another party's use of the Website;

Include the term "ChinaAMC" or any ChinaAMC trademark or executive's name, or any variation of the foregoing, as a meta-tag, hidden textual element;

Use any robot, spider, intelligent agent, other automatic device, or manual process to search, monitor or copy this website or the reports, data, information, content, software, products services, or other materials on, generated by or obtained from this website, whether through links or otherwise (collectively, "Materials"), without ChinaAMC HK's permission, provided that generally available third-party web browsers may be used without such permission; or

Use this website or the Materials in any manner that could create impression of affiliation, sponsorship or endorsement by ChinaAMC.

Limitation of Liability

All information contained in this website is published to the best of the knowledge and belief of ChinaAMC HK to be accurate at the time it was posted. However, no representation or warranty, expressed or implied is made by ChinaAMC HK as to its accuracy or completeness of the information or data provided in this website. ChinaAMC HK, its affiliates, directors, officers or employees accept no liability for any errors or omissions relating to information available in this website, and will not be liable for any damages or costs (including but not limited to lost profits, trading losses or damages that result from use or loss of use of this website) arising out of or in any way connected with (i) the use of the information provided in this website and (ii) any interruption or failure in system operation, delay in data transmission, computer virus or line or system failure.

Trademarks, Copyrights and other Intellectual Property

All copyright, trademarks and similar rights in this website and the information contained herein are owned by or licensed to ChinaAMC HK or its affiliate. Information in or any parts of this website cannot be reproduced, distributed or published.

Jurisdiction and Governing Law

These Terms shall be governed by, and shall be construed in accordance with, the laws of Hong Kong.  The courts of Hong Kong shall have non-exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Hong Kong.  Each party hereby waives any objection which it might at any time have to the courts of Hong Kong being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Hong Kong are not a convenient or appropriate forum.

Privacy Statement

We understand that our customers and website visitors are concerned about the privacy of information. The following information is designed to help you understand the information collection practices at this Website.

By visiting this Website, you are accepting the practices described in this Privacy Policy. If you do not agree to the below policy, please do not use this Website. 

ChinaAMC HK recognizes the importance of personal data to our business and the importance of respecting the privacy rights of our clients. Therefore, we are committed to ensuring compliance with the requirements of the Personal Data (Privacy) Ordinance (the "Ordinance"). Each employee of ChinaAMC HK must abide by our commitment to privacy in the handling of personal information. To further enhance confidentiality and security of all personal data, only authorized staff will be allowed to have access to the personal information collected. It is restricted to those persons who have a business need to access personal information in order to perform their job duties.

The purpose of this Statement is to establish the policies and practices of ChinaAMC HK's commitment to protect the privacy of personal data and to inform you about our responsibilities and your rights under the Ordinance.

Types of Personal Data Held 

Personal data held by us regarding clients may include the following:-

Name and address, occupation, contact details, date of birth, their identity card or passport numbers;

Current employer, nature of position, relevant income of clients;

Details of financial status of clients; and

Information obtained by us in the ordinary course of the business relationship such as, investment options, account values and balances etc.

Main Purposes of keeping Personal Data 

The purposes for which personal data relating to clients may be used are as follows:-

Facilitate the daily operations of the services provided to the clients;

Marketing investment products or services provided by ChinaAMC (HK);

Maintaining statistical data and providing a database for product and market research;

Marketing financial and/or investment products or services by any company/companies other than ChinaAMC HK, subject to client's express prior written consent;

Compliance with applicable laws and regulations; and

Any other purposes relating or incidental thereto.

Transfer of Personal Data 

Personal data held by ChinaAMC HK relating to clients will be kept confidential but may be transferred to the following parties (whether within or outside the Hong Kong Special Administrative Region) for any of the purposes stated above:-

Any agent, contractor, third party service provider or any member company of ChinaAMC HK which provides administrative, telecommunications, computer, marketing, professional or other services to ChinaAMC HK in connection with its business operations;

Any person to whom ChinaAMC HK is under an obligation to make disclosure under the requirements of any law binding on ChinaAMC HK or any of its member companies or under and for the purposes of any guidelines issued by regulatory or other authorities with which ChinaAMC HK or its member companies are expected to comply;

Any actual or proposed assignee of ChinaAMC HK or participant or sub-participant or transferee of ChinaAMC HK's rights in respect of the client; and

Any persons or bodies corporate under a duty of confidentiality to ChinaAMC HK.

Accuracy of Personal Data 

ChinaAMC HK strive at all times to ensure accuracy of all personal data collected and processed by us. In order to assist us to deliver on this pledge, please inform us immediately in the event that your personal information has been changed or you discovered that your personal information held by us is incorrect.

Your Rights 

It is not a statutory requirement for you to provide personal data to us. However, we will not be able to provide you with the services and products you may require unless you provide us with the necessary personal data or information.

You have a right (i) to be informed whether we hold any of your personal data; (ii) to be supplied with a copy of your personal data we hold; and (iii) to request correction of your personal data we hold. If you wish to access to and/or to correct any of your personal data held by us, please send your written request to the address set out below. We may, subject to the Ordinance, impose a reasonable fee for complying with a data access request.

If you do not wish your personal data to be used for direct marketing purposes, you may notify us in writing to the following address:-

Head of Legal & Compliance

China Asset Management (Hong Kong) Limited

37/F, Bank of China Tower, 

1 Garden Road, Central

Hong Kong

ChinaAMC Hang Seng Hong Kong Biotech Index ETF (3069 HK / 9069 HK)

Hong Kong-Listed ETFs

Management fee : 0.50%(p.a.)

Important Information about ChinaAMC Hang Seng Hong Kong Biotech Index ETF

Investment involves risks, including the loss of principle. Past performance is not indicative of future results. Before investing in the ChinaAMC Hang Seng Hong Kong Biotech Index ETF (the "Fund"), investor should refer to the Fund's prospectus for details, including the risk factors. You should not make investment decision based on the information on this material alone. Please note:

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Hang Seng Hong Kong-Listed Biotech Index (the "Index").
• The Fund is passively managed. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• The Fund’s investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
• The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
• The Fund is subject to concentration risks in biotech companies and in a particular geographical region (i.e. Hong Kong and mainland China). The Fund may be more volatile than a broadly-based fund.
• The Fund is exposed to risks associated with characters of biotech companies, such as pre-revenue, incurrence of net current liabilities, lower liquidity, higher volatility, dependency on intellectual property rights or patents, technological changes, increased regulations and intense competition.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• The Fund is subject to tracking error risk.
• If any suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter. The market price of units traded in each counter may deviate significantly.
• Unitholders will receive distributions in the HKD only. Non HKD based unitholder may have to bear bank or financial institution fees and charges associated with currency conversion.
• The Fund’s base currency is HKD but has units traded in USD. Investors may be subject to additional costs or losses associated with foreign currency fluctuations.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Investment Objective

The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Hang Seng Hong Kong-Listed Biotech Index.  

Fund Profile

Underlying Asset Class Equity   Domicile Hong Kong
Listing Date Mar-18-2021   Management Fee 0.5%(p.a.)
Base Currency HKD   Trustee and Registrar HSBC Institutional Trust Services (Asia) Limited
Net Asset Value (mil) 985.58   Distribution Policy Annually (usually in December), subject to the Manager’s discretion. All Units will receive distributions in HKD only.
As of 28-Jun-2022        

Intra-day Estimated NAV and Market Price ( 2,3 )

Latest Market Information ( 4,5 )

  Date Last Change Change(%)
Official NAV per Unit in HKD 28-Jun-2022 14.04 0.05 0.36
NAV per Unit in USD (for reference only*) 28-Jun-2022 1.79 0.01 0.38
Closing Price for HKD Traded Unit 28-Jun-2022 14.06 0.02 0.14
Closing Price for USD Traded Unit 28-Jun-2022 1.78 0.00 0.23

Trading Information

  HKD Traded Units USD Traded Units
Exchange Listing SEHK - Main Board SEHK - Main Board
Commencement of Dealing 18-Mar-2021 30-Jun-2021
Stock Code 3069 9069
Trading Board Lot Size 100 Units 100 Units
Trading Currency HKD USD
Reuters Code 3069.HK 9069.HK
ISIN Code HK0000711199 HK0000744208
Bloomberg Ticker 3069 HK 9069 HK
Bloomberg NAV 3069NAV 9069NAV
Bloomberg iNAV 3069IV 9069IV
Bloomberg Shares Oustanding 3069SHO 9069SHO

Index Information ( 6 )

Index Hang Seng Hong Kong-Listed Biotech Index
Index Provider Hang Seng Indexes Company Limited
Currency HKD
Closing Level 1389.73
Change 4.90
Change (%) 0.35
Type of Index Net Total Return
As of 28-Jun-2022  

Participating Dealers

ABN AMRO Clearing Hong Kong Limited
BNP Paribas Securities Services
China International Capital Corporation (Hong Kong) Limited
China Merchants Securities (HK) Co Ltd
Citigroup Global Markets Asia Limited
Credit Suisse Securities (Hong Kong) Limited
Goldman Sachs (Asia) Securities Limited
Guotai Junan Securities (Hong Kong) Limited
Haitong International Securities Group Limited
Huatai Financial Holdings (Hong Kong) Limited
J.P. Morgan Broking (Hong Kong) Limited
Korea Investment & Securities Asia Limited
Mirae Asset Securities (HK) Limited
The Hongkong and Shanghai Banking Corporation Limited

Market Makers

Market Makers  
HKD Counter USD Counter
Flow Traders Hong Kong Limited Flow Traders Hong Kong Limited
Haitong International Securities Company Limited  
HSBC Securities Brokers (Asia) Limited  
Vivienne Court Trading Pty. Ltd.  

Please refer to the Hong Kong Exchanges and Clearing Limited's website at for the latest lists of Market Makers.

1    Data are provided by ICE Data Indices, LLC (“ICE DATA”), is used with permission. ICE DATA, its Affiliates and their respective third party suppliers (including but not limited to Factset Research System, Inc.) disclaim any and all warranties and representations, express and/or implied, including any warranties of merchantability or fitness for a particular purpose or use, including the index data and any data included in, related to, or derived therefrom. Neither ICE DATA, its Affiliates nor their respective third party suppliers shall be subject to any damages or liability with respect to the adequacy, accuracy, timeliness or completeness of the Index data or any component thereof, and the index data and all components therefore are provided on an “as is” basis and your use is at your own risk. ICE DATA, its Affiliates and their respective third party suppliers do not sponsor, endorse, or recommend China Asset Management (Hong Kong) Limited, or any of its products or services.

2    Intra-day Estimated NAV per Unit calculations are performed by ICE DATA.

3    Intra-day Market Price refers to the market price of ChinaAMC Hang Seng Hong Kong Biotech Index on the date and at the time specified above, quoted from the Stock Exchange of Hong Kong Limited (the“SEHK”).
4    Change of the Official NAV per Unit in HKD indicate the change of the NAV per Unit since previous Dealing Day^. Please refer to the Prospectus for more information on the determination of the NAV.
5    TChanges of the Closing Price for HKD traded Units indicate the change of the closing price since previous SEHK trading day. Source of Closing Price: Bloomberg.
6   Benchmark Index returns are for illustrative purposes only and are not indicative of future results. Benchmark Index returns do not reflect any management fees, transaction costs or expenses. Change indicates the change since the last closing index level. Source: HSI, Bloomberg (see Terms and Conditions).

^ “Dealing Day” generally means a day on which (a) the SEHK is open; and (b) the Index is compiled and published. Please refer to the Prospectus for further details in this regard.

Investing involves risk, including possible loss of principal. Investment in emerging market countries may involve heightened risks such as increased volatility and lower trading volume, and may be subject to a greater risk of loss than investment in a developed country. Please carefully consider the Fund's investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the relevant Fund's prospectus. Please read the prospectus carefully before investing. ChinaAMC Funds are not sponsored, endorsed, issued, sold or promoted by their index providers (only applicable to ETFs and index funds). For details of an index provider including any disclaimer, please refer to the relevant ChinaAMC Fund offering documents.

Source: Fund performance and index data are provided by ChinaAMC and the relevant index providers (if applicable) respectively.

This website is prepared by China Asset Management (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission.